CPH •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCPH
Market Capitalization20,077 mln
Float56.67 mln
Earnings Date05/07/2026
EPS
89.39
Exceptional
P / E
3.28
Deeply undervalued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
145
Highly suspicious
1-Year Forecast
458
Exceptional upside
Relative Strength
91
/ 100
Top performer
Business Description
Founded in 1997 and headquartered in Søborg, Denmark, Zealand Pharma is a Danish biotech company that develops and sells medicines built from peptides, with operations in both Denmark and the United States. Its approved products include treatments for severe low blood sugar, while its research pipeline targets conditions such as congenital hyperinsulinism and short bowel syndrome. The company focuses on areas where patients have few or no existing treatment options, particularly in digestive and metabolic health.
